Physician profile
Arthur C Lee
NPI 1194899419
$44,210.19
in general payments reported to CMS, 2019-2025
17 companies · $3,368 in 2025
The $3,368 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $2,343 · 2021: $3,022 · 2022: $581 · 2023: $1,413 · 2024: $1,753 · 2025: $3,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,633 · Travel and Lodging: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,632.99 |
| Travel and Lodging | $900.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25,523.39 | 2019-2025 | Avvigo Guidance System, Rotapro |
| Abbott Laboratories | $8,284.98 | 2019-2025 | Aveir, Jot Dx, Coroflow |
| Medtronic Vascular, INC. | $4,340.01 | 2019-2020 | |
| Medtronic, INC. | $1,709.52 | 2021-2025 | Linq II, Onyx Frontier, Cobalt Dr Mri Surescan |
| Abiomed | $1,430.82 | 2021-2025 | Impella |
| Shockwave Medical, INC | $1,325.45 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $502.11 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $297.30 | 2019-2025 | Jardiance |
| Teleflex LLC | $183.76 | 2023 | Guideliner |
| Philips North America LLC | $161.96 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $124.58 | 2019 | |
| Penumbra, INC. | $110.03 | 2024 | Penumbra System |
| Elutia, INC. | $70.96 | 2019 | |
| Cardiva Medical, INC. | $63.47 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $43.18 | 2020-2023 | Brilinta |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.66 | 2020 | |
| Chiesi USA, INC. | $13.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.